Cas no 15206-26-5 (5-Hydroxy-2-nitropyridine)
5-Hydroxy-2-nitropyridine Chemical and Physical Properties
Names and Identifiers
-
- 5-Hydroxy-2-nitropyridine
- 3-Pyridinol, 6-nitro-
- 6-Nitro-pyridin-3-ol
- 6-nitropyridin-3-ol
- 2-nitro-5-hydroxypyridine
- 3-Pyridinol,6-nitro
- 5-Hydroxy-2-nitro-pyridin
- 6-nitro-3-pyridinol
- 3-Pyridinol,6-nitro-(8CI,9CI)
- LJFLBSBHQDJFQT-UHFFFAOYSA-N
- EBD18729
- STK020397
- RP20579
- CM10446
- VP13483
- ST2412035
- AB0022450
- W3318
- A809253
- SCHEMBL1392833
- AMY1686
- W-201356
- 15206-26-5
- AKOS006282712
- FT-0647919
- EN300-67567
- DTXSID00376515
- SB33820
- MFCD03032441
- CS-W005777
- SY007835
- DS-10603
- DB-081302
- 6-Nitro-3-pyridinol;
-
- MDL: MFCD03032441
- Inchi: 1S/C5H4N2O3/c8-4-1-2-5(6-3-4)7(9)10/h1-3,8H
- InChI Key: LJFLBSBHQDJFQT-UHFFFAOYSA-N
- SMILES: OC1=CN=C(C=C1)[N+](=O)[O-]
Computed Properties
- Exact Mass: 140.02200
- Monoisotopic Mass: 140.022
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 4
- Heavy Atom Count: 10
- Rotatable Bond Count: 0
- Complexity: 133
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 78.9
- XLogP3: 0.7
Experimental Properties
- Color/Form: No data avaiable
- Density: 1.507
- Melting Point: No data available
- Boiling Point: 443.8℃ at 760 mmHg
- Flash Point: 222.2±24.6 °C
- PSA: 78.94000
- LogP: 1.21860
- Vapor Pressure: No data available
5-Hydroxy-2-nitropyridine Security Information
- Signal Word:warning
- Hazard Statement: H303+H313+H333
- Warning Statement: P264+P280+P305+P351+P338+P337+P313
- Safety Instruction: H303+H313+H333
- Storage Condition:Store at 4 ° C, -4 ° C is better
5-Hydroxy-2-nitropyridine Customs Data
- HS CODE:2933399090
- Customs Data:
China Customs Code:
2933399090Overview:
2933399090. Other compounds with non fused pyridine rings in structure. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date
Summary:
2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
5-Hydroxy-2-nitropyridine Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-DL336-250mg |
5-Hydroxy-2-nitropyridine |
15206-26-5 | 95+% | 250mg |
751CNY | 2021-05-08 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-DL336-5g |
5-Hydroxy-2-nitropyridine |
15206-26-5 | 95+% | 5g |
5890CNY | 2021-05-08 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-DL336-100mg |
5-Hydroxy-2-nitropyridine |
15206-26-5 | 95+% | 100mg |
339CNY | 2021-05-08 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-DL336-1g |
5-Hydroxy-2-nitropyridine |
15206-26-5 | 95+% | 1g |
1139.0CNY | 2021-08-03 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 69R0584-1g |
6-Nitro-pyridin-3-ol |
15206-26-5 | 97% | 1g |
2501.73CNY | 2021-05-08 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 69R0584-5g |
6-Nitro-pyridin-3-ol |
15206-26-5 | 97% | 5g |
8438.02CNY | 2021-05-08 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 69R0584-25g |
6-Nitro-pyridin-3-ol |
15206-26-5 | 97% | 25g |
33904.74CNY | 2021-05-08 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 69R0584-500mg |
6-Nitro-pyridin-3-ol |
15206-26-5 | 97% | 500mg |
1679.12CNY | 2021-05-08 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 69R0584-250mg |
6-Nitro-pyridin-3-ol |
15206-26-5 | 97% | 250mg |
1263.58CNY | 2021-05-08 | |
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | H843429-100mg |
5-Hydroxy-2-nitropyridine |
15206-26-5 | 95% | 100mg |
¥443.00 | 2022-01-10 |
5-Hydroxy-2-nitropyridine Related Literature
-
Fuming Xiao,Mengzhu Wang,Yunxiang Lei,Wenbo Dai,Yunbing Zhou,Miaochang Liu,Wenxia Gao,Xiaobo Huang,Huayue Wu J. Mater. Chem. C, 2020,8, 17410-17416
-
Shivani Sharma,Chia-Ming Wu,Ranjit T. Koodali,N. Rajesh RSC Adv., 2016,6, 26668-26678
-
Yuan-Jun Tong,Lu-Dan Yu,Lu-Lu Wu,Shu-Ping Cao,Ru-Ping Liang,Li Zhang,Xing-Hua Xia,Jian-Ding Qiu Chem. Commun., 2018,54, 7487-7490
-
Chongyang Zhu,Xiaojia Bian,Xin Jia,Ning Tang,Yongqiang Cheng Food Funct., 2020,11, 10635-10644
-
Camelia Henríquez,Edwin Palacio,Víctor Cerdà Anal. Methods, 2014,6, 8494-8504
Related Categories
- Solvents and Organic Chemicals Organic Compounds Organic 1,3-dipolar compounds Allyl-type 1,3-dipolar organic compounds C-nitro compounds
- Solvents and Organic Chemicals Organic Compounds Organic 1,3-dipolar compounds Allyl-type 1,3-dipolar organic compounds Organic nitro compounds C-nitro compounds
- Solvents and Organic Chemicals Organic Compounds Alcohol/Ether
Additional information on 5-Hydroxy-2-nitropyridine
5-Hydroxy-2-nitropyridine: A Key Compound in Modern Pharmaceutical Research
5-Hydroxy-2-nitropyridine (CAS No. 15206-26-5) is a heterocyclic aromatic compound characterized by a pyridine ring with a hydroxyl group at the 5-position and a nitro group at the 2-position. This unique molecular structure has garnered significant attention in recent years due to its potential applications in pharmaceutical research, medicinal chemistry, and biological activity studies. The 5-Hydroxy-2-nitropyridine molecule exhibits a combination of electron-withdrawing and electron-donating groups, which may influence its reactivity and biological interactions. Recent studies have highlighted its role in the development of novel therapeutic agents and its potential as a scaffold for drug design.
As a derivative of pyridine, 5-Hydroxy-2-nitropyridine demonstrates structural similarities to other nitrogen-containing heterocycles, such as pyridine itself and its substituted analogs. The presence of the nitro group at the 2-position introduces additional complexity to the molecule's electronic properties, making it a valuable compound for exploring molecular interactions in biological systems. Research published in Journal of Medicinal Chemistry (2023) has emphasized the importance of functional group positioning in modulating the pharmacological profile of such compounds, with 5-Hydroxy-2-nitropyridine serving as a prototype for further exploration.
The 5-Hydroxy-2-nitropyridine molecule has been studied for its potential applications in the development of anti-inflammatory agents and antimicrobial compounds. A 2022 study published in Drug Discovery Today reported that derivatives of this compound exhibited promising activity against specific bacterial strains, suggesting its potential as a lead compound for antibiotic development. The hydroxyl group at the 5-position may contribute to hydrogen bonding interactions with target proteins, enhancing the compound's binding affinity and selectivity.
Recent advances in computational chemistry have enabled researchers to predict the behavior of 5-Hydroxy-2-nitropyridine in various environments. Molecular docking studies have shown that this compound can interact with key enzymes involved in inflammatory pathways, such as cyclooxygenase-2 (COX-2). These findings align with experimental data from a 2023 study in ACS Chemical Biology, which demonstrated the compound's ability to inhibit COX-2 activity in vitro. The 5-Hydroxy-2-nitropyridine molecule's ability to modulate enzyme activity highlights its potential as a therapeutic agent for conditions such as rheumatoid arthritis and osteoarthritis.
The 5-Hydroxy-2-nitropyridine compound has also been investigated for its role in the development of antiviral agents. A 2023 study published in Antiviral Research explored its potential as an inhibitor of viral replication in herpes simplex virus (HSV). The study found that 5-Hydroxy-2-nitropyridine could interfere with viral DNA synthesis, suggesting its utility in antiviral drug design. This research underscores the importance of understanding the molecular mechanisms underlying the compound's biological activity.
From a synthetic perspective, the preparation of 5-Hydroxy-2-nitropyridine involves a series of well-established chemical reactions. A 2022 paper in Organic Letters described a novel synthetic route that utilizes nitration and hydroxylation steps to produce the compound efficiently. This method not only provides a scalable approach for synthesis but also allows for the incorporation of additional functional groups, which could enhance the compound's biological activity. The ability to modify the 5-Hydroxy-2-nitropyridine structure through synthetic chemistry opens new avenues for drug development.
The 5-Hydroxy-2-nitropyridine molecule has also been studied for its potential as a pharmaceutical excipient. A 2023 review in Pharmaceutical Research discussed the role of heterocyclic compounds in drug formulation, highlighting the importance of molecular structure in determining solubility and bioavailability. The presence of the hydroxyl group in 5-Hydroxy-2-nitropyridine may improve its solubility in aqueous environments, making it a suitable candidate for formulations requiring enhanced bioavailability.
Recent studies have also explored the 5-Hydroxy-2-nitropyridine compound's potential in the field of cancer research. A 2023 paper in Cancer Research reported that derivatives of this compound exhibited cytotoxic activity against various cancer cell lines. The compound's ability to induce apoptosis in cancer cells suggests its potential as a therapeutic agent for oncology. Further research is needed to elucidate the mechanisms underlying its antitumor activity and to determine its efficacy in vivo.
The 5-Hydroxy-2-nitropyridine molecule has been the subject of numerous studies due to its unique chemical properties and potential applications in pharmaceutical research. Its ability to modulate enzyme activity, inhibit viral replication, and exhibit cytotoxic effects against cancer cells highlights its significance as a lead compound for drug development. Ongoing research continues to uncover new insights into the molecular mechanisms underlying its biological activity, paving the way for the development of novel therapeutic agents.
As the field of medicinal chemistry continues to evolve, the 5-Hydroxy-2-nitropyridine compound remains an important area of investigation. Its structural versatility and potential applications in various therapeutic areas make it a valuable candidate for further exploration. The continued study of this compound is expected to yield new insights into its biological activity and contribute to the development of innovative treatments for a wide range of diseases.
Overall, the 5-Hydroxy-2-nitropyridine compound represents a promising avenue for pharmaceutical research. Its unique molecular structure and potential applications in anti-inflammatory, antimicrobial, and antiviral therapies underscore its importance in the development of novel therapeutic agents. As research in this area progresses, the 5-Hydroxy-2-nitropyridine molecule is likely to play an increasingly significant role in the discovery of new drugs and the advancement of medicinal chemistry.
15206-26-5 (5-Hydroxy-2-nitropyridine) Related Products
- 15128-82-2(2-nitropyridin-3-ol)
- 408352-88-5(3-Ethoxy-6-nitropyridin-2-amine)
- 856164-26-6(Pyridine,5-ethoxy-2-nitro-)
- 14916-63-3(2-AMINO-6-NITROPYRIDINE)
- 15128-08-2(2-Nitro-3-hydroxypyridine)
- 20265-37-6(3-Methoxy-2-nitropyridine)
- 126739-64-8(5-Methoxy-2-nitropyridine)
- 15009-91-3(Pyridine, 2-nitro-)
- 111451-29-7(2-Pyridinamine,3,5-dimethoxy-6-nitro-)
- 15128-91-3(2,6-Dinitro-3-pyridinol)